Metabolic syndrome is a condition characterized by metabolic
alterations
that culminate in chronic noncommunicable diseases of high morbidity
and mortality, such as cardiovascular diseases, type 2 diabetes, nonalcoholic
fatty liver disease, and colon cancer. Developing new therapeutic
strategies with a multifactorial approach is important since current
therapies focus on only one or two components of the metabolic syndrome.
In this sense, plant-based gene regulation represents an innovative
strategy to prevent or modulate human metabolic pathologies, including
metabolic syndrome. Here, using a computational and systems biology
approach, it was found that carrot microRNAs can modulate key BMPs/SMAD
signaling members, C/EBPs, and KLFs involved in several aspects associated
with metabolic syndrome, including the hsa04350:TGF-beta signaling
pathway, hsa04931:insulin resistance, hsa04152:AMPK signaling pathway,
hsa04933:AGE-RAGE signaling pathway in diabetic complications, hsa04010:MAPK
signaling pathway, hsa04350:TGF-beta signaling pathway, hsa01522:endocrine
resistance, and hsa04910:insulin signaling pathway. These data demonstrated
the potential applications of carrot microRNAs as effective food-based
therapeutics for obesity and associated metabolic diseases.